Position in GILD
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$390,895
-$51,744 QoQ
Shares Held
3,094
-2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#1,508
of 2,266 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 74%
Shared 0%
None 26%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MBL Wealth, LLC holds $11,328,845 across 9 Drug Manufacturers - General names. GILD ranks #8 (3.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,439 | $2,925,409 | |
| 2 | JNJ |
Johnson & Johnson
|
10,383 | $2,636,970 | |
| 3 | ABBV |
AbbVie Inc.
|
7,862 | $1,978,393 | |
| 4 | MRK |
Merck & Co., Inc.
|
12,579 | $1,616,401 | |
| 5 | AMGN |
Amgen Inc
|
1,479 | $535,574 | |
| 6 | PFE |
Pfizer Inc
|
21,003 | $505,752 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
8,305 | $478,534 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
3,094 | $390,895 |
All Filings in GILD
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $390,895 | 3,094 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $442,639 | 3,176 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $389,208 | 3,171 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||